Furthermore, levels of circulating protein and mRNA encoding for interleukin- (IL)-1, IL-6 and tumor necrosis factor (TNF)-α are reduced by the administration of synthetic cannabinoids in preclinical models of multiple sclerosis and periodontitis (Abidi et al., 2018, Croxford and Miller, 2003). The gene discussed is TNF; the disease is periodontitis.